Literature DB >> 25334070

Restoration of miR-7 expression suppresses the growth of Lewis lung cancer cells by modulating epidermal growth factor receptor signaling.

Jingrong Li1, Yijie Zheng2, Gengyun Sun3, Shudao Xiong4.   

Abstract

microRNAs are an abundant class of short endogenous non-coding RNAs that function as important regulators of multiple target genes and participate in diverse biological roles in carcinogenesis. However, the role of miR-7 in lung cancer remains unclear and requires further elucidation. In the present study, we found a reduction of miR-7 expression in Lewis lung cancer (3LL) cells originating from mice by real-time RT-PCR. Restoration of miR-7 inhibited 3LL cell proliferation, induced cell apoptosis in vitro and reduced tumorigenicity in vivo. We further confirmed that miR-7 downregulated the expression of both epidermal growth factor receptor (EGFR) and murine leukemia viral oncogene homologue-1 (RAF-1) oncogenes by real-time PCR and western blot analysis. Furthermore, inhibition of EGFR showed similar effects to miR-7 enforcement in 3LL cells. Taken together, these findings revealed that miR-7 acts as an antitumor miRNA in 3LL by targeting and suppressing the expression of both EGFR and RAF-1 oncogenes. This study may provide a rationale for the use of miR-7 in lung cancer target therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25334070     DOI: 10.3892/or.2014.3519

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  17 in total

Review 1.  microRNA deregulation in keloids: an opportunity for clinical intervention?

Authors:  Xin Yu; Zheng Li; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2015-10-21       Impact factor: 6.831

2.  Circular RNA ciRS-7-A Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal Cancer.

Authors:  Wenhao Weng; Qing Wei; Shusuke Toden; Kazuhiro Yoshida; Takeshi Nagasaka; Toshiyoshi Fujiwara; Sanjun Cai; Huanlong Qin; Yanlei Ma; Ajay Goel
Journal:  Clin Cancer Res       Date:  2017-02-07       Impact factor: 12.531

3.  The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma.

Authors:  Liangliang Xu; Ming Zhang; Xiaobo Zheng; Pengsheng Yi; Chuan Lan; Mingqing Xu
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-10       Impact factor: 4.553

Review 4.  Role of microRNA-7 in digestive system malignancy.

Authors:  Wan-Qun Chen; Ling Hu; Geng-Xin Chen; Hai-Xia Deng
Journal:  World J Gastrointest Oncol       Date:  2016-01-15

5.  Promoter mutation of tumor suppressor microRNA-7 is associated with poor prognosis of lung cancer.

Authors:  Juanjuan Zhao; Kailing Wang; Zhenyuan Liao; Ying Li; Hang Yang; Chao Chen; Y A Zhou; Yijin Tao; Mengmeng Guo; Tao Ren; Lin Xu
Journal:  Mol Clin Oncol       Date:  2015-09-16

Review 6.  Circular RNAs as potential biomarkers for cancer diagnosis and therapy.

Authors:  Fengling Wang; Adil J Nazarali; Shaoping Ji
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

7.  Long noncoding RNA BMPR1B-AS1 facilitates endometrial cancer cell proliferation and metastasis by sponging miR-7-2-3p to modulate the DCLK1/Akt/NF-κB pathway.

Authors:  Tianjiao Lai; Haifeng Qiu; Lulu Si; Yu Zhen; Danxia Chu; Ruixia Guo
Journal:  Cell Cycle       Date:  2022-04-11       Impact factor: 5.173

Review 8.  Emerging Roles of MicroRNAs in EGFR-Targeted Therapies for Lung Cancer.

Authors:  Fei Han; Jinxi He; Feng Li; Jiali Yang; Jun Wei; William C Cho; Xiaoming Liu
Journal:  Biomed Res Int       Date:  2015-07-26       Impact factor: 3.411

9.  MicroR-545 enhanced radiosensitivity via suppressing Ku70 expression in Lewis lung carcinoma xenograft model.

Authors:  Chen Liao; Wei Xiao; Nuo Zhu; Zhiyuan Liu; Jiu Yang; Yanhu Wang; Mei Hong
Journal:  Cancer Cell Int       Date:  2015-05-28       Impact factor: 5.722

Review 10.  MicroRNA-7: a promising new target in cancer therapy.

Authors:  Juanjuan Zhao; Yijing Tao; Ya Zhou; Nalin Qin; Chao Chen; Dan Tian; Lin Xu
Journal:  Cancer Cell Int       Date:  2015-10-29       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.